Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.

Por Taskinen, M R, Bogardus, C, Kennedy, A, Howard, B V
Publicado em 1985

Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids

Por Vehmanen, L, Saarto, T, Blomqvist, C, Taskinen, M-R, Elomaa, I
Publicado em 2004

Characterization of lipase activities in obese Pima indians. Decreases with weight reduction.

Por Reitman, J S, Kosmakos, F C, Howard, B V, Taskinen, M R, Kuusi, T, Nikkila, E A
Publicado em 1982

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

Por Groop, P-H, Del Prato, S, Taskinen, M-R, Owens, D R, Gong, Y, Crowe, S, Patel, S, von Eynatten, M, Woerle, H-J
Publicado no Diabetes Obes Metab (2014)

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

Por Tahvanainen, E, Syvanne, M, Frick, M H, Murtomaki-Repo, S, Antikainen, M, Kesaniemi, Y A, Kauma, H, Pasternak, A, Taskinen, M R, Ehnholm, C
Publicado em 1998

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics

Por Björnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Sihlbom, C., Thorsell, A., Zhou, H., Taskinen, M.‐R., Borén, J.
Publicado no J Intern Med (2019)

Metabolic effects of liver transplantation in cirrhotic patients.

Por Luzi, L, Perseghin, G, Regalia, E, Sereni, L P, Battezzati, A, Baratti, D, Bianchi, E, Terruzzi, I, Hilden, H, Groop, L C, Pulvirenti, A, Taskinen, M R, Gennari, L, Mazzaferro, V
Publicado em 1997

Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B...

Por Pajukanta, P, Terwilliger, J D, Perola, M, Hiekkalinna, T, Nuotio, I, Ellonen, P, Parkkonen, M, Hartiala, J, Ylitalo, K, Pihlajamäki, J, Porkka, K, Laakso, M, Viikari, J, Ehnholm, C, Taskinen, M R, Peltonen, L
Publicado em 1999

Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.

Por Lehto, M, Tuomi, T, Mahtani, M M, Widén, E, Forsblom, C, Sarelin, L, Gullström, M, Isomaa, B, Lehtovirta, M, Hyrkkö, A, Kanninen, T, Orho, M, Manley, S, Turner, R C, Brettin, T, Kirby, A, Thomas, J, Duyk, G, Lander, E, Taskinen, M R, Groop, L
Publicado em 1997